Heikki Lanckriet
Chief Executive Officer en 4BASEBIO PLC .
Fortuna: 15 M $ al 31/03/2024
Perfil
Heikki Lanckriet is the founder of Expedeon Ltd.
(founded in 2003) and Expedeon Holdings Ltd.
(founded in 2003).
He is currently the CEO, Executive Director & Chief Scientific Officer at 4basebio Plc (since 2020) and holds various director positions at NeoPhore Ltd., Kither Biotech Srl, 4basebio Slu, 4basebio UK Ltd., Biofrontera, Inc., Heqet Therapeutics SRL, 4basebio Discovery Ltd., and I2i Capital Ltd.
He is also a Member-Supervisory Board at Biofrontera AG (since 2021).
Previously, he served as the Chief Executive Officer & Chief Scientific Officer at 2invest AG (2016-2020) and as an Independent Member-Supervisory Board at Epigenomics AG (2022-2024).
Dr. Lanckriet has also worked at Puratos NV and the University of Cambridge.
He holds a doctorate degree from the University of Cambridge and undergraduate and graduate degrees from Ghent University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
4BASEBIO PLC
9.46% | 02/02/2024 | 1 211 060 ( 9.46% ) | 15 M $ | 31/03/2024 |
Cargos activos de Heikki Lanckriet
| Empresas | Cargo | Inicio |
|---|---|---|
| 4BASEBIO PLC | Chief Executive Officer | 22/12/2020 |
| BIOFRONTERA AG | Director/Board Member | 14/12/2021 |
| BIOFRONTERA INC. | Director/Board Member | 12/07/2023 |
Expedeon Ltd.
 Expedeon Ltd. BiotechnologyHealth Technology Expedeon Ltd. develops and produces proteins for drug discovery. Its products include gel electrophoresis, nucleic acid kits, protein quantitation, western blotting reagents and spectroscopy. The firm provides genomics and proteomics tools to scientists. The company was founded by Heikki Lanckriet in 2003 and is headquartered in Cambridge, the United Kingdom. | Chief Executive Officer | 07/01/2010 |
Heqet Therapeutics SRL
 Heqet Therapeutics SRL Pharmaceuticals: MajorHealth Technology Heqet Therapeutics SRL is an Italian biotechnology company that specializes in cardiac regenerative medicine. The company is based in Turin, Italy. The company was founded by Mauro Giacca. Marta Antonucci has been the CEO of the company since 2022. | Director/Board Member | - |
| I2i Capital Ltd. | Director/Board Member | - |
NeoPhore Ltd.
 NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Director/Board Member | - |
| 4basebio Slu | Director/Board Member | - |
| 4basebio Discovery Ltd. | Director/Board Member | - |
| ░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Antiguos cargos conocidos de Heikki Lanckriet.
| Empresas | Cargo | Fin |
|---|---|---|
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formación de Heikki Lanckriet.
| University of Cambridge | Doctorate Degree |
| Ghent University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 5 |
|---|---|
| 2INVEST AG | Finance |
| EPIGENOMICS AG | Health Technology |
| BIOFRONTERA AG | Health Technology |
| 4BASEBIO PLC | Health Technology |
| BIOFRONTERA INC. | Health Technology |
| Empresas privadas | 10 |
|---|---|
Puratos NV
 Puratos NV Food: Specialty/CandyConsumer Non-Durables Puratos NV manufactures and supplies ingredients to the bakery, patisserie, and chocolate sectors. Its products include specialty bread mixes, emulsifiers, yeast, cakes, fruit and cream fillings, chocolate and nut fillings, and decoration solutions. The firm also offers recipes, flavoring preparations, glazes, icing, fudge, ganache and non-dairy toppings. The company was founded on September 28, 1989 and is headquartered in Groot-Bijgaarden, Belgium. | Consumer Non-Durables |
Expedeon Ltd.
Expedeon Ltd. BiotechnologyHealth Technology Expedeon Ltd. develops and produces proteins for drug discovery. Its products include gel electrophoresis, nucleic acid kits, protein quantitation, western blotting reagents and spectroscopy. The firm provides genomics and proteomics tools to scientists. The company was founded by Heikki Lanckriet in 2003 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Expedeon Holdings Ltd.
 Expedeon Holdings Ltd. BiotechnologyHealth Technology Expedeon Holdings Ltd. develops, manufactures, and commercializes proteomics reagents and tools. The company was founded on January 7, 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Commercial Services |
Kither Biotech Srl
 Kither Biotech Srl Pharmaceuticals: MajorHealth Technology Kither Biotech Srl is a biotechnology company, which engages in the research and development of pharmaceutical products. It focuses on the treatment of chronic inflammatory diseases. The company was founded by Emilio Hirsch, Marco Kevin Malisani, and Alberto Bardelli and is headquartered in Turin, Italy. | Health Technology |
| 4basebio Slu | |
4basebio UK Ltd.
 4basebio UK Ltd. Wholesale DistributorsDistribution Services 4basebio Ltd. engages in the genomics and DNA manufacturing business. The company was founded on November 5, 2019 and is headquartered in Cambridge, the United Kingdom. | Distribution Services |
Heqet Therapeutics SRL
Heqet Therapeutics SRL Pharmaceuticals: MajorHealth Technology Heqet Therapeutics SRL is an Italian biotechnology company that specializes in cardiac regenerative medicine. The company is based in Turin, Italy. The company was founded by Mauro Giacca. Marta Antonucci has been the CEO of the company since 2022. | Health Technology |
| 4basebio Discovery Ltd. | |
| I2i Capital Ltd. |
- Bolsa de valores
- Insiders
- Heikki Lanckriet
